Moderna in talks with Poland over investment while developing mRNA cancer therapy
US biotech firm Moderna, the mRNA vaccine pioneer, is in talks about investing in Poland – the company's CEO met with Poland's finance minister. The firm is also developing a novel mRNA-based cancer therapy. Details of any potential investment have not yet been disclosed.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!